UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Facteurs de croissance hématopoïétiques

Pathologie et biologie, 1994, Vol.42 (10), p.970-971

SYMANN, M

1994

Volltextzugriff (PDF)

International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas : Report of the jury

Journal of clinical oncology, 1999, Vol.17 (1), p.423-429

1999

Volltextzugriff (PDF)

Pitfalls in the detection of disseminated non-hematological tumor cells

Annals of oncology, 2000-07, Vol.11 (7), p.785-792

2000

Volltextzugriff (PDF)

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

European journal of cancer (1990), 1999-01, Vol.35 (1), p.54-59

1999

Volltextzugriff (PDF)

Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors

Bone marrow transplantation (Basingstoke), 1999-10, Vol.24 (7), p.769-775

1999

Volltextzugriff (PDF)

Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation

Blood, 1998-09, Vol.92 (5), p.1471-1490

1998

Volltextzugriff (PDF)

Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies : Lyon, France, June 4-6, 1993

Journal of clinical oncology, 1994, Vol.12 (1), p.226-231

1994

Volltextzugriff (PDF)

Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells

Current gene therapy, 2001-11, Vol.1 (4), p.359-366

2001

Volltextzugriff (PDF)

Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients

Bone marrow transplantation (Basingstoke), 2000-02, Vol.25 (3), p.243-249

2000

Volltextzugriff (PDF)

Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy : a multicentric placebo-controlled, randomized phase Ib study

Blood, 1995-05, Vol.85 (9), p.2347-2353

1995

Volltextzugriff (PDF)

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

Journal of clinical oncology, 1987-12, Vol.5 (12), p.1864-1873

1987

Volltextzugriff (PDF)

Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (14), p.3800-3807

1994

Volltextzugriff (PDF)

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

Annals of hematology, 2000-03, Vol.79 (3), p.152-157

2000

Volltextzugriff (PDF)

Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions

Current opinion in oncology, 1991-08, Vol.3 (4), p.648

Symann, M

1991

Volltextzugriff (PDF)

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury

Annals of oncology, 1999-01, Vol.10 (1), p.13-19

1999

Volltextzugriff (PDF)

Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4–6, 1993

Annals of oncology, 1994-01, Vol.5 (1), p.19-23

1994

Volltextzugriff (PDF)

Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines

Cancer research (Chicago, Ill.), 1993-07, Vol.53 (13), p.3139-3144

1993

Volltextzugriff (PDF)

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Blood, 1997-11, Vol.90 (9), p.3727-3734

1997

Volltextzugriff (PDF)

Induction and enhancement of normal human megakaryocyte polyploidization are concomitant with perturbation in the actin metabolism

European journal of clinical investigation, 1998-10, Vol.28 (10), p.845-855

1998

Volltextzugriff (PDF)

High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells

Bone marrow transplantation (Basingstoke), 1996-09, Vol.18 Suppl 1, p.S36

1996

Volltextzugriff (PDF)

Augmentation of the number of nucleolar organizer regions in human megakaryocyte cell lines after induction of polyploidization by a microtubule inhibitor

European journal of clinical investigation, 1998-02, Vol.28 (2), p.138-144

1998

Volltextzugriff (PDF)

ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue

Annals of oncology, 1999-08, Vol.10 (8), p.903-905

1999

Volltextzugriff (PDF)

Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.603-603

2009

Volltextzugriff (PDF)

Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts

Cancer research (Chicago, Ill.), 1989-09, Vol.49 (18), p.5058-5061

1989

Volltextzugriff (PDF)

Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies

Transfusion (Philadelphia, Pa.), 2003-01, Vol.43 (1), p.50-57

2003

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(81)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(85)
Life Sciences & Biomedicine
(75)
Science & Technology
(75)
Biological And Medical Sciences
(65)
Medical Sciences
(51)
Female
(46)
Oncology
(41)
Male
(32)
Middle Aged
(30)
Adult
(28)
Animals
(26)
Hematology
(26)
Pharmacology. Drug Treatments
(23)
Aged
(20)
Antineoplastic Agents
(20)
Mice
(20)
Hematopoietic Stem Cell Transplantation
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Colony-Forming Units Assay
(15)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Facteurs de croissance hématopoïétiques

International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas : Report of the jury

Pitfalls in the detection of disseminated non-hematological tumor cells

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

Unreliability of carcinoembryonic antigen (CEA) reverse transcriptase-polymerase chain reaction (RT-PCR) in detecting contaminating breast cancer cells in peripheral blood stem cells due to induction of CEA by growth factors

Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation

Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies : Lyon, France, June 4-6, 1993

Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells

Highly purified CD34+ cells isolated using magnetically activated cell selection provide rapid engraftment following high-dose chemotherapy in breast cancer patients

Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy : a multicentric placebo-controlled, randomized phase Ib study

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patients

Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury

Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies, Lyon, June 4–6, 1993

Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines

Primary Anaplastic Large-Cell Lymphoma in Adults: Clinical Presentation, Immunophenotype, and Outcome

Induction and enhancement of normal human megakaryocyte polyploidization are concomitant with perturbation in the actin metabolism

High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells

Augmentation of the number of nucleolar organizer regions in human megakaryocyte cell lines after induction of polyploidization by a microtubule inhibitor

ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue

Benefit of the Sequential Administration of Docetaxel after Standard FEC Regimen for Node-Positive Breast Cancer: Long-Term Follow-Up Results of the FNCLCC-PACS 01 Trial

Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts

Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies

Suchergebnisse filtern